What should be applied to an infiltrated intravenous line?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Infiltrated IV Line

For a general infiltrated IV line (non-chemotherapy), apply dry cold compresses for 20 minutes, 3-4 times daily for 1-2 days, elevate the limb, and avoid manual pressure over the affected area 1.

Immediate Management Steps

When you discover an infiltrated line, follow this algorithmic approach:

Step 1: Stop the Infusion Immediately

  • Leave the cannula in place initially
  • Do NOT remove it yet

Step 2: Aspirate Back Through the Line

  • Gently attempt to aspirate as much extravasated fluid as possible through the existing cannula 1
  • Document the volume removed in the patient record
  • Critical pitfall: Avoid applying manual pressure over the extravasated area, as this can worsen tissue damage by spreading the infiltrate 1

Step 3: Apply Cold Compresses

  • Use dry cold compresses (not ice directly on skin)
  • Apply for 20 minutes at a time
  • Repeat 3-4 times daily for 1-2 days
  • Avoid alcohol-based compresses 1

Step 4: Elevate the Affected Limb

  • Keep the limb elevated above heart level when possible
  • Administer analgesia as needed 1

Drug-Specific Antidotes (If Applicable)

The treatment diverges significantly based on what was infiltrated:

For Chemotherapy Vesicants:

Anthracyclines (doxorubicin, epirubicin, daunorubicin):

  • Dexrazoxane IV is the treatment of choice: 1000 mg/m² on days 1-2, then 500 mg/m² on day 3, starting within 6 hours of extravasation 1
  • Administer in a large vein away from the extravasation site (opposite arm)
  • Remove any ice packs 15 minutes before dexrazoxane administration
  • Do NOT use DMSO with dexrazoxane 1
  • Alternative: DMSO 99% topically - 4 drops per 10 cm² of affected skin, applied twice initially, then every 8 hours for 1 week 1

Vinca Alkaloids (vincristine, vinblastine):

  • Hyaluronidase: 1-6 mL of 150 U/mL solution injected through the existing IV line
  • Usual dose: 1 mL hyaluronidase solution per 1 mL of extravasated drug 1

Mechlorethamine:

  • Sodium thiosulfate: 2 mL of 1/6 molar solution subcutaneously
  • Prepare by mixing 4 mL of 10% sodium thiosulfate with 6 mL sterile water
  • Inject 2 mL for each milligram of mechlorethamine extravasated 1

For Non-Chemotherapy Infiltrations:

  • The vast majority (91%) require only elevation and observation 2
  • Cold compresses and elevation are the mainstays
  • Invasive intervention is almost never indicated for routine IV fluids or non-vesicant medications 2

What NOT to Do

Avoid subcutaneous corticosteroids - retrospective data shows 46% of patients receiving intralesional corticoids needed surgical debridement versus only 13% without corticoids, suggesting a deleterious effect 1.

When to Escalate Care

Consider surgical consultation if:

  • Tissue necrosis develops
  • Pain persists beyond 10 days
  • Progressive tissue breakdown occurs despite conservative management 1

Surgical debridement should include wide three-dimensional excision of all involved tissue, temporary biologic dressing coverage, and delayed split-thickness skin graft application at 2-3 days 1.

Documentation Requirements

Every infiltration must be documented with 1:

  • Patient identification
  • Date and time of infiltration
  • Drug/solution extravasated and diluent
  • Signs and symptoms
  • IV access description
  • Estimated extravasation area and volume
  • Management steps with timestamps
  • Photographic documentation when possible

Follow-Up Protocol

  • Review patient daily or every 2 days during the first week
  • Then weekly until complete symptom resolution
  • Early signs may be subtle but can progress to blistering and necrosis over days to weeks 1
  • Refer to plastic surgery if tissue breakdown develops

The key distinction in management is whether the infiltrated substance is a chemotherapy vesicant (requiring specific antidotes) versus routine IV fluids or medications (requiring only supportive care with cold compresses and elevation). Recent evidence shows that the composition of modern IV solutions has decreased the potential for harmful infiltration, making invasive intervention rarely necessary for non-chemotherapy infiltrates 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.